Sarah Gauthier

Background

About Sarah Gauthier

Accomplished Senior Associate Scientist with over five years of experience in clinical research, sample logistics, and laboratory operations, as well as supporting global vaccine development initiatives. Proven track record in managing cross-functional teams, ensuring compliance with GxP and OSHA standards, and optimizing clinical processes to meet critical study timelines. Holds a Bachelor’s degree in Biological Sciences and a Master’s in Clinical Research Administration with a focus on regulatory guidance and project management. Adept at developing training materials, fostering team growth, and collaborating with diverse stakeholders across international settings. Proficient in advanced laboratory techniques, scientific presentations, and data integrity management. Seeking to leverage expertise to drive innovation and operational excellence in Berlin's dynamic clinical research and development landscape. Leadership Highlights: • Vaccines, Antivirals, and Evidence Generation (VAEG) Team Lead: Led a team of Associate and Senior Associate Scientists in the cross-functional collaboration with study site personnel, Contract Research Organization (CRO) staff, and testing laboratories to document and resolve sample discrepancies, advance processes, and ensure timely data delivery for clinical and nonclinical vaccine trials • Sample Replacement Processing Team Lead: Directed a team of Associate and Senior Associate Scientists in the coordination of timely testing and replacement of clinical specimens, ensuring study timelines were met in partnership with Clinical Research Associates (CRAs), CROs, and internal Data Management Teams • Environmental Health and Safety Team Lead: Managed a team to of Associate and Senior Associate Scientists to uphold GxP and OSHA compliance, implementing risk mitigation strategies in partnership with corporate Environmental Health and Safety colleagues to enhance workplace safety •Training Coordinator: Designed and implemented training systems for clinical sites, specifically supporting global Phase 1-4 vaccine trials, to improve efficiency and ensure protocol adherence.